Showing results (601-610 of 622) with videos related to

Sort By:
Pageof 63
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|October 30, 2023
Standards for psychosocial care in pediatric cancer: adapted proposal for Latin American and Caribbean countriesViviana Trigoso, Liliana Vásquez, Soad Fuentes-Alabi, et al.
The New England Journal of Medicine|March 17, 2015
Long-term use of ticagrelor in patients with prior myocardial infarctionMarc P Bonaca, Deepak L Bhatt, Marc Cohen, et al.
Epigenetics & Chromatin|March 8, 2017
Assessing histone demethylase inhibitors in cells: lessons learnedStephanie B Hatch, Clarence Yapp, Raquel C Montenegro, et al.
Cell Chemical Biology|March 7, 2017
Potent and Selective KDM5 Inhibitor Stops Cellular Demethylation of H3K4me3 at Transcription Start Sites and Proliferation of MM1S Myeloma CellsAnthony Tumber, Andrea Nuzzi, Edward S Hookway, et al.
Molecular Therapy. Nucleic Acids|January 25, 2013
Systemic RNAi-mediated Gene Silencing in Nonhuman Primate and Rodent Myeloid CellsTatiana I Novobrantseva, Anna Borodovsky, Jamie Wong, et al.
Archives of Osteoporosis|November 26, 2025
Epidemiology of hip fracture in Iraq and development of a country-specific FRAX modelAhmed Abdulbari, Nizar A Jassim, Yasir H Motlaq, et al.
Lancet (London, England)|October 9, 2018
Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trialErin A Bohula, Benjamin M Scirica, Silvio E Inzucchi, et al.
Neuro-Oncology|July 12, 2025
RANO seizure working group-Tumor Related Epilepsy Assessment Tool (RANO-TREAT) to assess seizure control for glioma treatment trials and clinical practiceEdward K Avila, Anne S Reiner, Terri S Armstrong, et al.
Neuro-Oncology|January 14, 2025
Benchmarking the Efficacy of Salvage Systemic Therapies for Recurrent Meningioma: A RANO Group Systematic Review and Meta-analysis to Guide Clinical Trial DesignRupesh Kotecha, Eyub Y Akdemir, Tugce Kutuk, et al.
European Journal of Medicinal Chemistry|June 4, 2019
C8-substituted pyrido[3,4-d]pyrimidin-4(3H)-ones: Studies towards the identification of potent, cell penetrant Jumonji C domain containing histone lysine demethylase 4 subfamily (KDM4) inhibitors, compound profiling in cell-based target engagement assaysYann-Vaï Le Bihan, Rachel M Lanigan, Butrus Atrash, et al.
Pageof 63